Phase 3 topline data from azetukalner FOS epilepsy program planned for H2 2025 in support of NDA filing and potential commercial launch– First ...
Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the period January - December 2024. The report is available on ...
New Delhi: Accepting the bioequivalence study report for Type 2 Diabetes Mellitus, the Subject Expert Committee (SEC) ...
Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?
We recently published a list of 10 Worst Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are ...
Learn more about whether Alnylam Pharmaceuticals, Inc. or argenx SE is a better investment based on AAII's A+ Investor grades ...
8h
News Medical on MSNElderly populations: Global trends in the healthy aging marketA global elderly and aging population has significant impacts, not only in terms of individual health risk but in terms of ...
ACCESS and ACCESS II studies fully enrolled; topline data from both studies anticipated by year-end 2025Oral small ...
As Rare Disease Day is commemorated on 28 February, experts discuss the barriers to gene therapy access for some rare ...
A 24-year-old woman from York has become one of the first patients in the world to take part in a pioneering research study ...
RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and OS Therapies Inc. (NYSE American:OSTX) on the RedChip Small Stocks, Big Money™ show, a sponsored ...
8h
News Medical on MSNStress & Distress: Designing clinical trials for maximum efficacyThe stress axis that has been most extensively studied in relation to stress is unquestionably the hypothalamic pituitary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results